Literature DB >> 3790541

Characterization of an associated equilibrium folding intermediate of bovine growth hormone.

D N Brems, S M Plaisted, E W Kauffman, H A Havel.   

Abstract

In the preceding paper [Havel, H. A., Kauffman, E. W., Plaisted, S. M., & Brems, D. N. (1986) Biochemistry (preceding paper in this issue)], an associated intermediate was shown to be highly populated during the equilibrium denaturation of bovine growth hormone. In this paper, we describe its partial characterization and propose a mechanism for association. The associated equilibrium intermediate is populated under conditions that induce partial denaturation and at protein concentrations greater than 0.2 mg/mL. The remaining nativelike helical structure present in the partially denatured species is implicated in the mechanism of association as demonstrated by similar concentration dependencies and thermal stabilities of the helix and the associated equilibrium intermediate. Furthermore, it is suggested that a putative amphiphilic helix from residues 110-127 plays a critical role in the association as demonstrated by a diminution of the associated equilibrium intermediate when mixed with the peptide fragment 96-133. A model is proposed to account for these results in which partial denaturation exposes the segment of the protein corresponding to the hydrophobic face of the putative amphiphilic helix 110-127. This metastable form is the species from which association occurs. Association is stabilized by the hydrophobic interactions resulting from intermolecular packing of the lipophilic faces of the helices. The implications of these results to protein folding studies are described.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3790541     DOI: 10.1021/bi00369a030

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  12 in total

1.  Association of partially-folded intermediates of staphylococcal nuclease induces structure and stability.

Authors:  V N Uversky; A S Karnoup; R Khurana; D J Segel; S Doniach; A L Fink
Journal:  Protein Sci       Date:  1999-01       Impact factor: 6.725

Review 2.  Stability of protein pharmaceuticals.

Authors:  M C Manning; K Patel; R T Borchardt
Journal:  Pharm Res       Date:  1989-11       Impact factor: 4.200

3.  Protein fragments as probes in the study of protein folding mechanisms: differential effects of dihydrofolate reductase fragments on the refolding of the intact protein.

Authors:  J G Hall; C Frieden
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

4.  Protein structural conformation and not second virial coefficient relates to long-term irreversible aggregation of a monoclonal antibody and ovalbumin in solution.

Authors:  Harminder Bajaj; Vikas K Sharma; Advait Badkar; David Zeng; Sandeep Nema; Devendra S Kalonia
Journal:  Pharm Res       Date:  2006-05-25       Impact factor: 4.200

5.  Conformation of P22 tailspike folding and aggregation intermediates probed by monoclonal antibodies.

Authors:  M A Speed; T Morshead; D I Wang; J King
Journal:  Protein Sci       Date:  1997-01       Impact factor: 6.725

6.  Stabilization of an associated folding intermediate of bovine growth hormone by site-directed mutagenesis.

Authors:  D N Brems; S M Plaisted; H A Havel; C S Tomich
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

7.  Structural characterization of the two refold dimers of recombinant bovine somatotropin (bST).

Authors:  J S Tou; B N Violand; M R Schlittler; M G Jennings
Journal:  J Protein Chem       Date:  1993-04

8.  Analysis of the contribution of an amphiphilic alpha-helix to the structure and to the function of ricin A chain.

Authors:  K N Morris; I G Wool
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-02       Impact factor: 11.205

9.  Covalent tethering of the dimer interface annuls aggregation in thymidylate synthase.

Authors:  S Agarwalla; R S Gokhale; D V Santi; P Balaram
Journal:  Protein Sci       Date:  1996-02       Impact factor: 6.725

10.  Non-native intermediate conformational states of human growth hormone in the presence of organic solvents.

Authors:  Muppalla Sukumar; Sacha M Storms; Michael R De Felippis
Journal:  Pharm Res       Date:  2005-05-17       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.